THE WOODLANDS, Texas — McKesson Specialty Health and the U.S. Oncology Network on Friday announced that Marcus Neubauer accepted the position of medical director of oncology services for McKesson Specialty Health, effective March 1.
“Dr. Neubauer is a respected and impressive physician who is committed to advancing the quality and science of cancer care,” stated Roy Beveridge, chief medical officer for McKesson Specialty Health and the U.S. Oncology Network. “With more than two decades of medical experience and his intimate knowledge of pathways, diagnostics and community-based patient care, he is the perfect fit for this position.”
In his new role, Neubauer will serve as the primary medical liaison between physicians in the U.S. Oncology Network and physicians and executives within the National Comprehensive Cancer Network. This includes ensuring that the recently announced Value Pathways powered by NCCN are 100% concordant with NCCN Clinical Practice Guidelines in Oncology and that they are well integrated in a clinical quality and regimen support system — an important step in ensuring patients receive the highest quality treatment while offering options to address costs of cancer care, McKesson Specialty noted.
Neubauer will serve as the physician lead for the suite of payer-facing solutions delivered to oncology providers, and will support the development and marketing of quality solutions and programs to providers, payers and employers.
Neubauer has been heavily involved in the U.S. Oncology Network for more than 15 years. He serves as chair of the U.S. Oncology Network Pathways Task Force, sits on the editorial board of the Journal of Oncology Practice and most recently served as an oncologist with Kansas City Cancer Center. He has been published more than 20 times and is a member of the American Society of Clinical Oncology. Neubauer is board certified in internal medicine and medical oncology.